The use of ProstaDoz in patients with chronic prostatitis. Results of a multicenter nonrandomized clinical study - Abstract

The main purpose of the study was to determine the effectiveness of a multicomponent dietary supplement ProstaDoz in patients with chronic prostatitis.

The study included 50 men with clinical symptoms of a chronic prostatitis, which were observed in 9 clinical centers in different regions of Russia. All patients have received 2 capsules of ProstaDoz twice a day for 1 month, followed by dynamic observation for 4 weeks. Symptomatic improvement was achieved in 46 (92%) patients. Evaluation of effects of ProstaDoz on various groups of symptoms has revealed that it reduces pain, promotes urination normalization and improvement of quality of life. These effects were maintained during all follow-up period.

 

Reference: Urologiia. 2013 Nov-Dec;(6):67-70, 72.


PubMed Abstract
PMID: 24649768

Article in Russian.

UroToday.com Prostatitis Section